Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEddI: Once-Daily vs Twice-Daily ART Adherence in HIV
NCT00214435Phase 4Unknown
- Sponsor
- 407 Doctors
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine, efavirenz, didanosine in human immunodeficiency virus infection (HIV), sponsored by 407 Doctors. Status: unknown.
02
Drugs
lamivudineefavirenzdidanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00214435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214435.